Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Iveda Solutions, Inc. Filed by: Iroquois Capital Management, LLC

May 15, 2026 8:54 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 585,068 shares of Common Stock issuable upon the exercise of the Warrants (as defined in Item 4). As more fully described in Item 4, the Warrants are subject to 4.99% Beneficial Ownership Blockers, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 585,068 shares of Common Stock issuable upon the exercise of the Warrants (as defined in Item 4). As more fully described in Item 4, the Warrants are subject to 4.99% Beneficial Ownership Blockers, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 585,068 shares of Common Stock issuable upon the exercise of the Warrants (as defined in Item 4). As more fully described in Item 4, the Warrants are subject to 4.99% Beneficial Ownership Blockers, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The Warrants are not currently exercisable due to the Beneficial Ownership Blockers. The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.


SCHEDULE 13G



Iroquois Capital Management, LLC
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe, President
Date:05/14/2026
Richard Abbe
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe
Date:05/14/2026
Kimberly Page
Signature:/s/ Kimberly Page
Name/Title:Kimberly Page
Date:05/14/2026

Categories

SEC Filings